Search For "cipl"
Cipla gets regulatory nod for launch of Ciplenza to treat mild to moderate
Updated : 5 years, 10 months ago IST
Mumbai (Maharashtra) [India], July 24 (ANI): Pharmaceutical major Cipla said on Friday it has been granted regulatory approval by the Drug Controller General of India (DCGI) for the launch of Favipiravir in the country under the brand name Ciplenza.
Read More
COVID-19: DCGI nod to Jubilant Generics to manufacture, sell remdesivir f
Updated : 5 years, 10 months ago IST
New Delhi [India], July 20 (ANI): The Drug Controller General of India (DCGI) has granted permission to pharma giant- Jubilant Generics Ltd to manufacture and market the anti-viral drug remdesivir for "restricted emergency use" on hospitalised COVID-19 patients, a senior health ministry offi
Read More
DCGI instructs pharma giants manufacturing remdesivir to upload details of
Updated : 5 years, 10 months ago IST
New Delhi [India], July 9 (ANI): Witnessing the incidence of black marketing and overcharging of the remdesivir injection above MRP, the Drugs Controller General of India (DCGI) has directed all three pharma giants--Cipla, Hetero, and Mylan to upload the details of anti-viral Remedsivir drug
Read More
Sensex closes 180 points up, Glenmark Pharma jumps 27 pc
Updated : 5 years, 11 months ago IST
Mumbai (Maharashtra) [India], June 22 (ANI): Equity benchmark indices wiped out early gains but closed over half a per cent higher on Monday led by gains in banking, pharma and metal stocks.
Read More
Glenmark, Cipla stocks surge after nod to launch drugs for mild-to-moderat
Updated : 5 years, 11 months ago IST
Mumbai (Maharashtra) [India], June 22 (ANI): Glenmark Pharmaceuticals' share price surged 30 per cent on Monday to Rs 531.80 per unit after it became the first pharmaceutical company in India to receive regulatory approval to make and sell oral antiviral drug favipiravir for treating mild-to
Read More
Equity indices trade higher as banking, pharma stocks rally
Updated : 5 years, 11 months ago IST
Mumbai (Maharashtra) [India], June 22 (ANI): Equity benchmark indices rose by nearly 1 per cent during early hours on Monday led by gains in banking, pharma and metal stocks.
Read More
Domestic pharma giants-- Cipla, Hetero got DCGI's nod to manufacture, sell
Updated : 5 years, 11 months ago IST
New Delhi [India], June 21 (ANI): In a significant development, India's top drug regulator has given nod to two domestic pharmaceutical companies--Cipla and Hetero for marketing authorization of anti-viral drug Remdesivir only for "restricted emergency use" on COVID-19 patients with moderate
Read More
Cipla expands partnership with Roche Pharma to improve access for oncology
Updated : 5 years, 11 months ago IST
Mumbai (Maharashtra) [India], June 18 (ANI): Pharmaceutical majors Cipla and Roche Products India said on Thursday they have entered into an agreement to provide better access to innovative medicines for patients in India.
Read More
Six Indian companies applied to CDSCO for permission to manufacture, marke
Updated : 5 years, 11 months ago IST
New Delhi [India], June 14 (ANI): The Centre on Sunday said that six Indian companies -- Hetero, Cipla, BDR, Jubilant, Mylan and Dr Reddy's Labs -- have applied to Indian Drug Regulatory Agency, Central Drug Standard Control Organisation (CDSCO) for permission to manufacture and market the R
Read More
Cipla to acquire 21.85 pc stake in GoApptiv, expand reach in small towns
Updated : 5 years, 11 months ago IST
Mumbai (Maharashtra) [India], June 10 (ANI): Pharmaceutical major Cipla said on Wednesday it will acquire 21.85 per cent stake in GoApptiv to expand the reach of its key brands in tier three plus towns.
Read More
COVID-19: Cipla enters into licensing pact with Gilead to manufacture and
Updated : 6 years ago IST
Mumbai (Maharashtra) [India], May 13 (ANI): Pharmaceutical major Cipla said on Wednesday it has signed a non-exclusive licensing agreement with Gilead Sciences Inc for manufacturing and distributing investigational medicine Remdesivir which has been issued an emergency use authorisation by t
Read More
Cipla sets up Rs 25 crore COVID-19 dedicated fund
Updated : 6 years, 1 month ago IST
Mumbai (Maharashtra) [India], April 21 (ANI): Pharmaceutical major Cipla on Tuesday announced a Rs 25 crore fund to support the government's efforts to effectively combat COVID-19 pandemic, including a voluntary donation of Rs 3 crore from its employees.
Read More